During the growth of a tumor, the need for oxygen and nutrients is provided by the development of new vascular beds. This process, named angiogenesis, is indispensable for tumor growth and metastasis development. Angiogenesis in tumors is induced by the release of growth factors like vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) which are released by the tumor cells. These factors, especially VEGF, have been shown to be highly upregulated in tumors and play a pivotal role in the proliferation and migration of endothelial cells into the tumor. Hypoxia is a common feature of human and animal tumors. The vast majority of human cancers have a median P02, well below the level of their tissue origin. As the tumor grows, the center of the tumor became more and more hypoxic, sometimes producing central necrosis. Pioneer observations by Keshet and colleagues. established that VEGF was highly expressed in the most hypoxic and ischemic areas of the tumors, suggesting that the lack of oxygen was an important stimuli for VEGF production. Indeed, work by others as well as our group have shown that the transcription of the VEGF gene is strongly stimulated by hypoxia. The mechanism of hypoxic regulation of VEGF is similar to the one originally described for the erythropoietin gene, and involves the HIF-1 (hypoxia inducible factor-1) complex. HIF-1 complex is a heterodimer composed of two basic helix-loop-helix proteins, HIF-1alpha, and hypoxia regulated protein, and HIF1alpha, which is constitutively expressed. HIF-1alpha is continuously synthesized but rapidly degraded by the ubiquitin- proteasome system under normoxic conditions. Hypoxia, transition metals and iron chelators inhibit HIFI a degradation and allow the formation of the active HIF- I complex. Recent work from our laboratory as well as other laboratories have shown that the VHL protein is involved in the degradation of HIF-1alpha. Tumors lacking VHL are highly vascularized and express high levels of VEGF mRNA and protein. In these tumor cells, HIF-1alpha protein is expressed in normoxic conditions due to a low degradation rate. The mechanisms by which the VHL protein induces normoxic degradation of HIF- 1alpha will be studied using a two-hybrid system in yeast. These will allow the identification and cloning of the protease involved in HIF-1alpha degradation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA089212-01
Application #
6228837
Study Section
Radiation Study Section (RAD)
Program Officer
Mohla, Suresh
Project Start
2001-02-01
Project End
2005-01-31
Budget Start
2001-02-01
Budget End
2002-01-31
Support Year
1
Fiscal Year
2001
Total Cost
$256,246
Indirect Cost
Name
Thomas Jefferson University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Bartrons, Ramon; Caro, Jaime (2007) Hypoxia, glucose metabolism and the Warburg's effect. J Bioenerg Biomembr 39:223-9
Kong, Xianguo; Alvarez-Castelao, Beatriz; Lin, Zhao et al. (2007) Constitutive/hypoxic degradation of HIF-alpha proteins by the proteasome is independent of von Hippel Lindau protein ubiquitylation and the transactivation activity of the protein. J Biol Chem 282:15498-505
Kong, Xianguo; Lin, Zhao; Caro, Jaime (2006) Immunophilin-ligands FK506 and CsA inhibit HIF1alpha expression by a VHL- and ubiquitin-independent mechanism. FEBS Lett 580:6182-6
Kong, Xianguo; Lin, Zhao; Liang, Dongming et al. (2006) Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha. Mol Cell Biol 26:2019-28
Minchenko, Oleksandr; Opentanova, Iryna; Caro, Jaime (2003) Hypoxic regulation of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene family (PFKFB-1-4) expression in vivo. FEBS Lett 554:264-70
Sang, Nianli; Stiehl, Daniel P; Bohensky, Jolene et al. (2003) MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300. J Biol Chem 278:14013-9
Minchenko, Alexander; Leshchinsky, Irene; Opentanova, Irina et al. (2002) Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect. J Biol Chem 277:6183-7
Sang, Nianli; Caro, Jaime; Giordano, Antonio (2002) Adenoviral E1A: everlasting tool, versatile applications, continuous contributions and new hypotheses. Front Biosci 7:d407-13
Sang, Nianli; Fang, Jie; Srinivas, Vickram et al. (2002) Carboxyl-terminal transactivation activity of hypoxia-inducible factor 1 alpha is governed by a von Hippel-Lindau protein-independent, hydroxylation-regulated association with p300/CBP. Mol Cell Biol 22:2984-92
Srinivas, V; Leshchinsky, I; Sang, N et al. (2001) Oxygen sensing and HIF-1 activation does not require an active mitochondrial respiratory chain electron-transfer pathway. J Biol Chem 276:21995-8

Showing the most recent 10 out of 11 publications